Behrad Derakhshan, Chief Business Officer at Edgewise Therapeutics, Inc. (EWTX), sold 10,000 shares at $30.03 ($300K) on 2025-02-05, disclosed to the SEC on 2025-02-07.
Open-market sale of $300k EWTX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2025-05-07 | $28K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.4M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $32K | — | Filing → |